Thalomid (thalidomide capsules) — Cigna

Initial criteria

• Patient age ≥ 18 years AND
• Patient has Langerhans cell histiocytosis with single-system multifocal skin disease OR relapsed or refractory disease OR has Rosai-Dorfman cutaneous disease

Approval duration

1 year